Page last updated: 2024-08-18

isomethyleugenol and Lymphoma, Mantle-Cell

isomethyleugenol has been researched along with Lymphoma, Mantle-Cell in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Dogan, A; Jain, P; Kanagal-Shamanna, R; Kim, DH; Li, S; Martinez-Baquero, D; McDonnell, TJ; Medeiros, LJ; Miranda, RN; Mo, H; O'Malley, DP; Ok, CY; Sakhdari, A; Vega, F; Wang, ML; Young, KH1
Huang, YQ; Ma, XD; Zheng, XK; Zou, Y; Zou, ZK1
Romanchikova, N; Trapencieris, P1
Kanduri, C; Kanduri, M; Ntoufa, S; Papakonstantinou, N; Rosenquist, R; Sander, B; Stamatopoulos, K; Sutton, LA1
Czader, M; Dave, SS; Dunphy, CH; Dunson, D; Fedoriw, Y; Gill, JI; Hsi, ED; Hsu, DS; Jima, D; Levy, S; Liu, Q; Lock, E; Love, C; Moffitt, AB; Richards, KL; Scotland, P; Sun, Z; Zhang, J1
Barbash, O; Boriack-Sjodin, PA; Chan-Penebre, E; Chesworth, R; Copeland, RA; Duncan, KW; Gallagher, KT; Ho, TF; Jacques, SL; Jin, L; Johnston, LD; Kruger, R; Kuplast, KG; Lingaraj, T; Majer, CR; Moyer, MP; Munchhof, MJ; Nurse, K; Oza, KP; Pappalardi, M; Pollock, RM; Raimondi, A; Ribich, SA; Rioux, N; Scott, MP; Smith, JJ; Stickland, K; Waters, NJ; West, KA; Wigle, TJ1
Hirota, S; Imai, Y; Matsuda, I1
Chim, CS; Loong, F; Srivastava, G; Wong, KY1

Other Studies

8 other study(ies) available for isomethyleugenol and Lymphoma, Mantle-Cell

ArticleYear
EZH2 expression is associated with inferior overall survival in mantle cell lymphoma.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021, Volume: 34, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Cell Proliferation; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histones; Humans; Immunohistochemistry; Lymphoma, Mantle-Cell; Male; Methylation; Middle Aged; Predictive Value of Tests; Risk Assessment; Risk Factors; Time Factors; Transcriptome; Treatment Outcome

2021
Silencing of LSD1 gene modulates histone methylation and acetylation and induces the apoptosis of JeKo-1 and MOLT-4 cells.
    International journal of molecular medicine, 2017, Volume: 40, Issue:2

    Topics: Acetylation; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Histone Code; Histone Demethylases; Histones; Humans; Lymphoma, Mantle-Cell; Methylation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA Interference; RNA, Small Interfering

2017
Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma.
    Anticancer research, 2019, Volume: 39, Issue:8

    Topics: Cell Line, Tumor; Cell Proliferation; Coumarins; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Histone Code; Histone Methyltransferases; Histones; Humans; Lymphoma, Mantle-Cell; Methylation; Polycomb Repressive Complex 2

2019
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma.
    Epigenetics, 2013, Volume: 8, Issue:12

    Topics: Chromatin; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Gene Expression Regulation; Gene Silencing; Genes, Homeobox; Histones; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Mantle-Cell; Methylation; Polycomb Repressive Complex 2

2013
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
    Blood, 2014, May-08, Volume: 123, Issue:19

    Topics: Ataxia Telangiectasia Mutated Proteins; B-Lymphocytes; Burkitt Lymphoma; Chromatin; Cyclin D1; DNA Helicases; DNA-Binding Proteins; Epigenesis, Genetic; Exome; Gene Regulatory Networks; Genomics; Germinal Center; Histone-Lysine N-Methyltransferase; Histones; Humans; Lymphoma, Mantle-Cell; Methylation; Mutation; Neoplasm Proteins; Nuclear Proteins; Repressor Proteins; Retinoblastoma Protein; Sequence Analysis, DNA; Shelterin Complex; Telomere-Binding Proteins; Transcription Factors; Tumor Suppressor Protein p53

2014
A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.
    Nature chemical biology, 2015, Volume: 11, Issue:6

    Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Isoquinolines; Lymphoma, Mantle-Cell; Male; Methylation; Mice, Inbred Strains; Models, Molecular; Molecular Structure; Protein Binding; Protein-Arginine N-Methyltransferases; Pyrimidines; snRNP Core Proteins; Xenograft Model Antitumor Assays

2015
Global histone modification profiles are well conserved between normal B lymphocytes and neoplastic counterparts.
    Pathology oncology research : POR, 2010, Volume: 16, Issue:3

    Topics: Acetylation; Adult; Aged; B-Lymphocytes; Female; Germinal Center; Histones; Humans; Immunohistochemistry; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Male; Methylation; Middle Aged; Protein Processing, Post-Translational

2010
Absence of ATM hypermethylation in mantle cell and follicular lymphoma.
    Leukemia, 2005, Volume: 19, Issue:5

    Topics: Ataxia Telangiectasia Mutated Proteins; Base Sequence; Cell Cycle Proteins; DNA-Binding Proteins; Humans; Lymphoma, Follicular; Lymphoma, Mantle-Cell; Methylation; Molecular Sequence Data; Mutation; Protein Serine-Threonine Kinases; Sequence Analysis, DNA; Tumor Suppressor Proteins

2005